STipe Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Liquidation

STipe Therapeutics General Information

Description

Operator of a biopharmaceutical company designed to harness the innate immune system to battle cancer. The company offers first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway, enabling oncology professionals to modulate the tumor microenvironment and enhance anti-tumoral responses.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Gorrissen Federspiel
  • Axeltorv 2
  • 1609 Copenhagen
  • Denmark
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Gorrissen Federspiel
  • Axeltorv 2
  • 1609 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

STipe Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation 01-Oct-2023 Completed Bankruptcy: Liquidation
6. Accelerator/Incubator Completed Generating Revenue
5. Early Stage VC (Series A) 30-Sep-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2018 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2018 Completed Startup
2. Grant 01-Jan-2018 $1.59M Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view STipe Therapeutics’s complete valuation and funding history, request access »

STipe Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 37,036 $118.52 $118.52 1x $118.52 15.46%
Ordinary 78,388 $119 $119 1x $119 32.73%
To view STipe Therapeutics’s complete cap table history, request access »

STipe Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company designed to harness the innate immune system to battle cancer. The company offer
Drug Discovery
Copenhagen, Denmark
24 As of 2023

San Carlos, CA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

STipe Therapeutics Competitors (56)

One of STipe Therapeutics’s 56 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iovance Biotherapeutics Corporation San Carlos, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Selecta Biosciences Formerly VC-backed Watertown, MA
MonTa BioSciences Venture Capital-Backed Lyngby, Denmark
You’re viewing 5 of 56 competitors. Get the full list »

STipe Therapeutics Patents

STipe Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4445917-A1 Sting sensitising agents Inactive 14-Apr-2023
EP-4445918-A1 Sting sensitising agents Inactive 14-Apr-2023
WO-2024213783-A1 Sting sensitising agents Inactive 14-Apr-2023
US-20240350647-A1 Sting sensitizing agents Inactive 14-Apr-2023
WO-2022003152-A2 Compositions comprising extracellular vesicles and sting stimulatory agents Inactive 03-Jul-2020 C12N5/0636
To view STipe Therapeutics’s complete patent history, request access »

STipe Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

STipe Therapeutics FAQs

  • When was STipe Therapeutics founded?

    STipe Therapeutics was founded in 2018.

  • Where is STipe Therapeutics headquartered?

    STipe Therapeutics is headquartered in Copenhagen, Denmark.

  • What is the size of STipe Therapeutics?

    STipe Therapeutics has 24 total employees.

  • What industry is STipe Therapeutics in?

    STipe Therapeutics’s primary industry is Drug Discovery.

  • Is STipe Therapeutics a private or public company?

    STipe Therapeutics is a Private company.

  • What is STipe Therapeutics’s current revenue?

    The current revenue for STipe Therapeutics is .

  • How much funding has STipe Therapeutics raised over time?

    STipe Therapeutics has raised $22.5M.

  • Who are STipe Therapeutics’s competitors?

    Iovance Biotherapeutics, Adaptimmune Therapeutics, Cristal Therapeutics, Selecta Biosciences, and MonTa BioSciences are some of the 56 competitors of STipe Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process